Ventriculoperitoneal (VP) Shunt Placement
Treatment for Neural Tube Defects
Typical Dosage: N/A (surgical procedure)
Effectiveness
90%
Safety Score
55%
Clinical Trials
500
Participants
100K
Comparative Safety Scale(Higher is safer)
Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
55
DangerousModerateSafe
Treatment Details
Dosage Range
N/A (surgical procedure)
Time to Effect
Immediate
Treatment Duration
Lifetime (requires ongoing management and potential revisions)
Evidence Quality
HIGHNumber Needed to Harm (NNH)
5(Treat 5 patients to see 1 additional serious adverse event)
Confidence Score
95%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$0
Monitoring:$1,500
Side Effect Mgmt:$5,000
Total Annual:$46,500
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENTQALYs Gained
12
Outcome-Based Costs
Cost per Responder
$48,947.37
Ventriculoperitoneal (VP) Shunt Placement Outcomes
for Neural Tube Defects
Efficacy Outcomes
Overall Effectiveness
+90%
Response Rate
+95%
Common Side Effects
Shunt malfunction (occlusion, disconnection)
+35%
Shunt infection
+10%
Overdrainage (slit ventricle syndrome)
+7%
Seizures
+7%
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov